179 related articles for article (PubMed ID: 7566967)
1. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
[TBL] [Abstract][Full Text] [Related]
2. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
3. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
Katzav S
Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
[TBL] [Abstract][Full Text] [Related]
4. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
5. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
6. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
7. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.
Cox AD; Brtva TR; Lowe DG; Der CJ
Oncogene; 1994 Nov; 9(11):3281-8. PubMed ID: 7936652
[TBL] [Abstract][Full Text] [Related]
8. Vav: Captain Hook for signal transduction?
Katzav S
Crit Rev Oncog; 1995; 6(2):87-97. PubMed ID: 8792085
[TBL] [Abstract][Full Text] [Related]
9. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
10. Vav: function and regulation in hematopoietic cell signaling.
Bonnefoy-Bérard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A
Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692
[TBL] [Abstract][Full Text] [Related]
11. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
12. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
13. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
Hu P; Margolis B; Schlessinger J
Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
[TBL] [Abstract][Full Text] [Related]
14. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation.
Groysman M; Nagano M; Shaanan B; Katzav S
Oncogene; 1998 Sep; 17(12):1597-606. PubMed ID: 9794237
[TBL] [Abstract][Full Text] [Related]
15. Functional interactions between isolated SH2 domains and insulin/Ras signaling pathways of Xenopus oocytes: opposite effects of the carboxy- and amino-terminal SH2 domains of p85 PI 3-kinase.
Aroca P; Mahadevan D; Santos E
Oncogene; 1996 Nov; 13(9):1839-46. PubMed ID: 8934529
[TBL] [Abstract][Full Text] [Related]
16. Immortalization by truncated myc or ras genes and synergism between myc and ras genes in cell transformation.
Spandidos DA; Lang JC
Anticancer Res; 1989; 9(4):1149-52. PubMed ID: 2683993
[TBL] [Abstract][Full Text] [Related]
17. trans-Dominant suppressor mutations of the H-ras oncogene.
Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
[TBL] [Abstract][Full Text] [Related]
18. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
19. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
Huff SY; Quilliam LA; Cox AD; Der CJ
Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain.
Machide M; Mano H; Todokoro K
Oncogene; 1995 Aug; 11(4):619-25. PubMed ID: 7651724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
